Investment Summary |
|
|---|---|
| Date | 2022-06-23 |
| Target | Vantage MedTech |
| Sector | Medical Products |
| Investor(s) | Ampersand Capital Partners |
| Deal Type | Growth Capital |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 72 of 84 |
| Sector (Medical Products) | 17 of 17 |
| Type (Growth Capital) | 22 of 24 |
| State (New Jersey) | 7 of 7 |
| Country (United States) | 61 of 69 |
| Year (2022) | 7 of 11 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-06-02 |
Vernal Biosciences
Colchester, Vermont, United States Vernal Biosciences provides mRNA and LNP-mRNA manufacturing services to democratize the use of mRNA for all use cases ranging from drug discovery to clinical development across all use cases such as gene editing and regulation, cellular programming, vaccines, mRNA replacement, oncology, autoimmune, and protein degradation. Vernal Biosciences is based in Colchester, Vermont. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-08-25 |
Phosphorex
Hopkinton, Massachusetts, United States Phosphorex is specializes in long-acting formulations, nanomedicine, and nucleic acid delivery solutions for leading pharmaceutical and biotechnology companies. Phosphorex was founded in 2005 and is based in Hopkinton, Massachusetts. |
Buy | - |
